In conclusion, this study establishes a link between increased TSPO and worsening AD pathology (Aβ and Tau) and is supportive for a role of TSPO in decreasing glycolysis and increasing astrocytic reactivity in the human hippocampus. The gene discussed is MAPT; the disease is Alzheimer disease.